July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET) radiotracer that is ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
June 10, 2017 — GE Healthcare showcased positron emission tomography (PET) and single photon emission computed ...
July 7, 2017 — Blood clots in veins and arteries can lead to heart attack, stroke and pulmonary embolism, which are ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
June 20, 2017 — Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F ...
An estimated one in seven American men will be affected by prostate cancer in their lifetime. Prostate-specific ...
In the battle against metastatic prostate cancer, the removal of lymph node metastases using image-guided surgery may ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is ...
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major ...
Philips announced that it will be showcasing molecular imaging solutions highlighting Philips’ commitment to innovation ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
Siemens Healthineers announced that the Food and Drug Administration (FDA) has cleared Biograph Horizon Flow edition, a ...
The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic ...
Oncologists have access to advanced imaging technologies for excellent cancer patient care with the new Celesteion ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine & Molecular ...
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the ...
May 15, 2017 — Blue Earth Diagnostics announced that the Trial Steering Committee recommended further recruitment be ...
The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging. The term was ...
The continuum of personalized care, covering individualized prevention and therapy, translates into multiple changes to ...
May 2, 2017 — In a first-ever molecular drug-imaging study in children, researchers in The Netherlands used whole-body ...
April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the ...
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American ...
July 14, 2017 